603658 安图生物
已收盘 10-19 15:00:00
资讯
新帖
简况
安图生物(603658)10月13日主力资金净卖出161.20万元
证券之星 · 10-14
安图生物(603658)10月13日主力资金净卖出161.20万元
股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》
证券之星 · 10-13
股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》
安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%
证券之星 · 10-09
安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%
股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》
证券之星 · 10-09
股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》
股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》
证券之星 · 10-08
股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》
安图生物(603658)9月29日主力资金净买入225.86万元
证券之星 · 09-30
安图生物(603658)9月29日主力资金净买入225.86万元
安图生物(603658)9月28日主力资金净卖出717.15万元
证券之星 · 09-29
安图生物(603658)9月28日主力资金净卖出717.15万元
安图生物涨7.53%,国金证券四周前给出“买入”评级
证券之星 · 09-22
安图生物涨7.53%,国金证券四周前给出“买入”评级
安图生物:公司将于9月30日召开2026年半年度业绩说明会
证券日报 · 09-21
安图生物:公司将于9月30日召开2026年半年度业绩说明会
安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”
证券之星 · 09-15
安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”
安图生物获得发明专利授权:“诺卡氏菌鉴定的试剂组合及其应用”
证券之星 · 09-11
安图生物获得发明专利授权:“诺卡氏菌鉴定的试剂组合及其应用”
股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》
证券之星 · 09-07
股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》
每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围
证券之星 · 09-06
每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围
安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%
证券之星 · 09-04
安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%
股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》
证券之星 · 08-31
股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》
每周股票复盘:安图生物(603658)股东户数降7.09%
证券之星 · 08-30
每周股票复盘:安图生物(603658)股东户数降7.09%
股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%
证券之星 · 08-26
股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%
安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%
证券之星 · 08-25
安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%
国金证券:给予安图生物买入评级
证券之星 · 08-25
国金证券:给予安图生物买入评级
图解安图生物中报:第二季度单季净利润同比下降13.43%
证券之星 · 08-25
图解安图生物中报:第二季度单季净利润同比下降13.43%
加载更多
公司概况
公司名称:
郑州安图生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-01
主营业务:
郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。
发行价格:
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":32.22,"timestamp":1792393200000,"preClose":31.57,"halted":0,"volume":2657989,"delay":0,"changeRate":0.0206,"floatShares":571000000,"shares":571000000,"eps":1.7398,"marketStatus":"已收盘","change":0.65,"latestTime":"10-19 15:00:00","open":31.75,"high":32.4,"low":31.6,"amount":85300600,"amplitude":0.0253,"askPrice":32.22,"askSize":27,"bidPrice":32.21,"bidSize":105,"shortable":0,"etf":0,"ttmEps":1.7398,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":5,"adr":0,"adjPreClose":31.57,"symbolType":"stock","openAndCloseTimeList":[[1792373400000,1792380600000],[1792386000000,1792393200000]],"highLimit":34.73,"lowLimit":28.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571424768,"isCdr":false,"pbRate":2.12,"roa":"--","peRate":18.51937,"roe":"5.49%","epsLYR":1.87,"committee":0.612648,"marketValue":18411000000,"turnoverRate":0.0047,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-20。","floatMarketCap":18411000000},"requestUrl":"/m/hq/s/603658","defaultTab":"news","newsList":[{"id":"2675396815","title":"安图生物(603658)10月13日主力资金净卖出161.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675396815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675396815?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:32","pubTimestamp":1791937927,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,安图生物报收于32.45元,下跌1.93%,换手率0.41%,成交量2.35万手,成交额7652.58万元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入506.16万元,融资偿还504.25万元,融资净买入1.91万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675105804","title":"股市必读:安图生物新发布《安图生物关于公司及子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675105804","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675105804?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:53","pubTimestamp":1791827590,"startTime":"0","endTime":"0","summary":"公司公告汇总:安图生物及子公司获多项医疗器械注册证,涵盖HIV核酸检测试剂盒、全自动凝血分析仪等,注册证有效期均为5年。公司公告汇总安图生物关于公司及子公司获得医疗器械注册证的公告郑州安图生物工程股份有限公司及全资子公司安图实验仪器(郑州)、二级子公司郑州标源近日收到国家药品监督管理局和河南省药品监督管理局颁发的医疗器械注册证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK0239","159883","BK1100","603658","BK1583","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674086810","title":"安图生物(603658)披露使用闲置募集资金进行现金管理赎回公告,10月09日股价上涨0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674086810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674086810?lang=zh_cn&edition=full","pubTime":"2026-10-09 23:03","pubTimestamp":1791558198,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,安图生物报收于33.45元,较前一交易日上涨0.72%,最新总市值为191.14亿元。公告显示,公司于2026年10月9日赎回使用非公开发行股票闲置募集资金购买的可转让大额存单1,000万元,获得利息收益21.14万元;同日赎回通用回购逆回购3,000万元,获得利息收益3.62万元。公司此前已履行相关审议程序,授权使用闲置募集资金进行现金管理。截至公告日,最近十二个月累计实际收益3,310.96万元,尚未收回本金金额141,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900039035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674017260","title":"股市必读:安图生物新发布《安图生物关于完成工商变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674017260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674017260?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:26","pubTimestamp":1791480369,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总:10月8日主力资金净流出995.62万元,占总成交额7.96%; 公司公告汇总:安图生物已完成经营范围变更及《公司章程》修订的工商登记手续,取得换发的新《营业执照》。公司公告汇总安图生物关于完成工商变更登记的公告郑州安图生物工程股份有限公司于2026年8月24日召开第五届董事会第十三次会议,审议通过变更公司经营范围暨修订《公司章程》的议案,并经2026年9月14日第一次临时股东大会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301493","title":"股市必读:安图生物新发布《安图生物关于全资子公司完成医疗器械经营许可证及药品经营许可证变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673301493?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:10","pubTimestamp":1791393017,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,安图生物报收于34.08元,上涨1.4%,换手率0.62%,成交量3.55万手,成交额1.21亿元。医疗器械经营许可证经营范围涵盖多个类别,经营方式为批零兼营并提供运输、贮存服务,许可期限至2030年5月21日;药品经营许可证经营范围为体外诊断试剂(药品),含冷藏药品,经营方式为批发,有效期至2029年6月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1574","09996","BK1100","603658","159883","BK1583","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122529","title":"安图生物(603658)9月29日主力资金净买入225.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671122529?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:33","pubTimestamp":1790728432,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月29日收盘,安图生物报收于33.61元,下跌1.52%,换手率0.48%,成交量2.73万手,成交额9245.61万元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1173.34万元,融资偿还979.3万元,融资净买入194.04万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126645","title":"安图生物(603658)9月28日主力资金净卖出717.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671126645?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:21","pubTimestamp":1790641309,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,安图生物报收于34.13元,上涨1.43%,换手率0.66%,成交量3.8万手,成交额1.3亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1427.53万元,融资偿还1527.67万元,融资净偿还100.14万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669626117","title":"安图生物涨7.53%,国金证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669626117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669626117?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:37","pubTimestamp":1790066276,"startTime":"0","endTime":"0","summary":"今日安图生物涨7.53%,收盘报34.97元。2026年8月25日,国金证券研究员甘坛焕,何冠洲发布了对安图生物的研报《海外创新加速突破,拓展长期增长点》,该研报对安图生物给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为10.16、11.38、13.55亿元,同比-5%、+12%、+19%,现价对应PE为19、17、14倍,维持“买入”评级。安图生物个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200028574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669165982","title":"安图生物:公司将于9月30日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2669165982","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669165982?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:31","pubTimestamp":1789990260,"startTime":"0","endTime":"0","summary":"证券日报网讯9月21日,安图生物发布公告称,公司将于2026年9月30日16:00-17:00召开2026年半年度业绩说明会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-21/doc-inisqvrw5750709.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-21/doc-inisqvrw5750709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0239","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667369350","title":"安图生物获得实用新型专利授权:“一种粪便幽门螺杆菌检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667369350","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667369350?lang=zh_cn&edition=full","pubTime":"2026-09-15 03:32","pubTimestamp":1789414323,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安图生物新获得一项实用新型专利授权,专利名为“一种粪便幽门螺杆菌检测装置”,专利申请号为CN202521850648.8,授权日为2026年9月15日。上述粪便幽门螺杆菌检测装置,解决了现有检测装置步骤繁琐、需频繁直视样本的技术问题,实现了操作简便,无需频繁直视样本的技术效果。今年以来安图生物新获得专利授权27个,较去年同期增加了68.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500002407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666552513","title":"安图生物获得发明专利授权:“诺卡氏菌鉴定的试剂组合及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666552513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666552513?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:38","pubTimestamp":1789069091,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安图生物新获得一项发明专利授权,专利名为“诺卡氏菌鉴定的试剂组合及其应用”,专利申请号为CN202511413634.4,授权日为2026年9月1日。今年以来安图生物新获得专利授权26个,较去年同期增加了62.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100007535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936270","title":"股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665936270?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:21","pubTimestamp":1788715269,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,上涨1.82%,换手率0.44%,成交量2.52万手,成交额8292.9万元。公司公告汇总:安图生物拟终止“体外诊断产品产能扩大项目”,将81,187.63万元剩余募集资金转投至“体外诊断产品研发中心项目”,并新增智慧化实验室产品开发内容及四家实施主体,相关事项尚需股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366887","title":"每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366887?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:57","pubTimestamp":1788634628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,较上周的33.07元下跌0.27%。本周,安图生物9月2日盘中最高价报33.48元。安图生物当前最新总市值188.46亿元,在医疗器械板块市值排名13/129,在两市A股市值排名1032/5214。本周关注点来自公司公告汇总:安图生物拟终止“体外诊断产品产能扩大项目”,将剩余募集资金81,187.63万元转投至“体外诊断产品研发中心项目”。公司同时拟变更经营范围,增加通用设备制造、专用设备制造及机械设备销售,并修订《公司章程》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333468","title":"安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333468","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664333468?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:41","pubTimestamp":1788514877,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,较前一交易日上涨1.82%,最新总市值为188.46亿元。该股当日开盘32.88元,最高33.2元,最低32.26元,成交额达8292.9万元,换手率为0.44%。近日,安图生物发布《2026年第一次临时股东会会议材料》公告。公司拟终止2020年非公开发行股票募投项目中的‘体外诊断产品产能扩大项目’,并将剩余募集资金81,187.63万元转投至‘体外诊断产品研发中心项目’。上述事项尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400031627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047074","title":"股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047074","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047074?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:26","pubTimestamp":1788128772,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,安图生物报收于33.07元,下跌1.34%,换手率0.39%,成交量2.24万手,成交额7421.24万元。当日关注点交易信息汇总:8月28日主力资金净流入768.12万元,占总成交额10.35%。公司公告汇总:安图生物及二级子公司郑州标源获5项医疗器械注册证,涵盖可溶性ST2蛋白检测等体外诊断相关产品,注册证有效期均为5年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK1574","BK0239","159883","BK1583","BK1100","09996","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048882","title":"每周股票复盘:安图生物(603658)股东户数降7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048882?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:50","pubTimestamp":1788036618,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,安图生物报收于33.07元,较上周的34.6元下跌4.42%。本周,安图生物8月24日盘中最高价报34.99元。股本股东变化股东户数变动截至2026年6月30日,安图生物股东户数为3.48万户,较3月31日减少2655户,减幅为7.09%。公司公告汇总安图生物2026年半年度报告摘要公司总资产为11,784,102,379.83元,较上年度末减少4.11%;归属于上市公司股东的净资产为8,674,379,764.28元,较上年度末减少2.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752633","title":"股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662752633?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:37","pubTimestamp":1787690230,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润4.97亿元,同比下降12.94%;第二季度单季度归母净利润2.61亿元,同比下降13.43%。业绩披露要点财务报告2026年中报显示,上半年度主营收入20.58亿元,同比下降0.12%;归母净利润4.97亿元,同比下降12.94%;扣非净利润4.93亿元,同比下降9.73%;第二季度单季度主营收入10.66亿元,同比上升0.13%;单季度归母净利润2.61亿元,同比下降13.43%;单季度扣非净利润2.61亿元,同比下降9.91%;负债率25.6%,投资收益2971.9万元,财务费用1715.65万元,毛利率67.25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600008060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662385597","title":"安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662385597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662385597?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:38","pubTimestamp":1787650713,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安图生物披露,截至2026年6月30日公司股东户数为3.48万户,较3月31日减少2655.0户,减幅为7.09%。在医疗器械行业个股中,安图生物股东户数高于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.13万户。从股价来看,2026年3月31日至2026年6月30日,安图生物区间跌幅为9.72%,在此期间股东户数减少2655.0户,减幅为7.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662783079","title":"国金证券:给予安图生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662783079","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662783079?lang=zh_cn&edition=full","pubTime":"2026-08-25 12:21","pubTimestamp":1787631715,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对安图生物进行研究并发布了研究报告《海外创新加速突破,拓展长期增长点》,给予安图生物买入评级。 盈利预测 预计公司2026-2028年归母净利润分别为10.16、11.38、13.55亿元,同比-5%、+12%、+19%,现价对应PE为19、17、14倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。本文数据来源于国金证券股份有限公司,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500024125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203384","title":"图解安图生物中报:第二季度单季净利润同比下降13.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203384?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:56","pubTimestamp":1787594162,"startTime":"0","endTime":"0","summary":"证券之星消息,安图生物2026年中报显示,上半年度公司主营收入20.58亿元,同比下降0.12%;归母净利润4.97亿元,同比下降12.94%;扣非净利润4.93亿元,同比下降9.73%;其中2026年第二季度,公司单季度主营收入10.66亿元,同比上升0.13%;单季度归母净利润2.61亿元,同比下降13.43%;单季度扣非净利润2.61亿元,同比下降9.91%;负债率25.6%,投资收益2971.9万元,财务费用1715.65万元,毛利率67.25%。财报数据概要请见下图:本文数据来源于安图生物2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792409244244,"stockEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0205},{"period":"6month","weight":-0.0379},{"period":"1year","weight":-0.1513},{"period":"ytd","weight":-0.0724}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34787人(较上一季度减少7.09%)","perCapita":"16426股","listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","registeredCapital":"57142万元","survey":" 郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。","listedPrice":14.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}